Human Detection Gene Chip

Gene Target Group has been engaged in precision health services and genetic technology R&D for many years. It has been awarded substantial R&D funding support from the Ministry of Economic Affairs' Taiwan Industry Innovation Platform (TIIP). Using a cancer detection chip as a model, the company has established standardized development procedures, clinical trial modules, and mass production facilities for genetic chips and nucleic acid detection automation instruments. These technologies will be applied in the future to virus detection, major disease analysis, veterinary medicine, and green energy analytics.

The chips developed by Gene Target Group are capable of accurately analyzing over 300 genes and multiple disease categories in a single test. For example, in the case of Covid-19, this chip technology could be used to simultaneously detect all virus strains. When applied to major diseases such as cancer, the chip can help assess cancer risk with precision even before the disease develops.